bluebird bio is a biotechnology company focused on developing curative gene therapies for severe genetic diseases. With a decade of experience, the company has pioneered gene therapy treatments for conditions such as beta-thalassemia, cerebral adrenoleukodystrophy, and sickle cell disease. Their FDA-approved one-time gene therapy for sickle cell disease highlights their commitment to delivering life-changing treatments. bluebird bio leverages proprietary lentiviral vector gene therapies, offering a functional copy of a gene to a patient's own cells. The company emphasizes diversity, equity, inclusion, and patient advocacy as part of its mission to improve patient outcomes and drive the field of gene therapy forward.
gene therapy β’ gene addition β’ sickle cell disease β’ beta-thalassemia β’ cerebral adrenoleukodystrophy
201 - 500 employees
Founded 2010
𧬠Biotechnology
π Pharmaceuticals
βοΈ Healthcare Insurance
π° $113.6M Post-IPO Equity on 2023-01
3 days ago
Join bluebird bio to empower patients with education on gene therapies for severe genetic diseases.
πΊπΈ United States β Remote
π° $113.6M Post-IPO Equity on 2023-01
β° Full Time
π Senior
π΄ Lead
π« Community Manager
π¦ H1B Visa Sponsor
March 21
Oversee US Medical Information strategies for gene therapies at bluebird bio. Ensure comprehensive execution across the franchise.
πΊπΈ United States β Remote
π° $113.6M Post-IPO Equity on 2023-01
β° Full Time
π΄ Lead
π Director
π¦ H1B Visa Sponsor
Remote Jobs at bluebird bio